Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 1
2019 3
2020 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Does increase of symptoms mean progression?
Marosi C, Urbanic Purkart T. Marosi C, et al. Among authors: urbanic purkart t. Neuro Oncol. 2022 Dec 1;24(12):2170-2171. doi: 10.1093/neuonc/noac218. Neuro Oncol. 2022. PMID: 36112492 Free PMC article. No abstract available.
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.
Kurz SC, Stammberger A, Rosahl SK, Abrey LE, Albert NL, von Baumgarten L, Gempt J, Grosu AL, Leidgens V, McLean A, Renovanz M, Schwarzenberger J, Sevenich L, Urbanic Purkart T, Combs SE, Tabatabai G, Hegi M, Nowosielski M. Kurz SC, et al. Among authors: urbanic purkart t. Neuro Oncol. 2023 Dec 8;25(12):2302-2304. doi: 10.1093/neuonc/noad157. Neuro Oncol. 2023. PMID: 37738478 No abstract available.
miR-497 and 219 in blood aid meningioma classification.
Abdelrahman A, Negroni C, Sahm F, Adams CL, Urbanic-Purkart T, Khalil M, Vergura R, Morelli C, Hanemann CO. Abdelrahman A, et al. Among authors: urbanic purkart t. J Neurooncol. 2022 Oct;160(1):137-147. doi: 10.1007/s11060-022-04126-0. Epub 2022 Sep 8. J Neurooncol. 2022. PMID: 36076132
Vanishing midbrain mass lesion - A germinoma?
Purkart TU, Seifert-Held T, Haybäck J, Holl E, Asslaber M, Payer F, Fazekas F. Purkart TU, et al. J Neurol Sci. 2019 Sep 15;404:40-43. doi: 10.1016/j.jns.2019.06.013. Epub 2019 Jun 13. J Neurol Sci. 2019. PMID: 31325666 No abstract available.
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
Heugenhauser J, Galijasevic M, Mangesius S, Goebel G, Buchroithner J, Erhart F, Pichler J, Widhalm G, Stockhammer G, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Czech T, Surböck B, Urbanic Purkart T, Marosi C, Felzmann T, Nowosielski M. Heugenhauser J, et al. Among authors: urbanic purkart t. Cancers (Basel). 2022 Mar 20;14(6):1579. doi: 10.3390/cancers14061579. Cancers (Basel). 2022. PMID: 35326730 Free PMC article.
Vitamin D and Hyperkinetic Movement Disorders: A Systematic Review.
Homann CN, Ivanic G, Homann B, Purkart TU. Homann CN, et al. Among authors: purkart tu. Tremor Other Hyperkinet Mov (N Y). 2020 Aug 25;10:32. doi: 10.5334/tohm.74. Tremor Other Hyperkinet Mov (N Y). 2020. PMID: 32908795 Free PMC article.
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.
Nenning KH, Gesperger J, Furtner J, Nemc A, Roetzer-Pejrimovsky T, Choi SW, Mitter C, Leber SL, Hofmanninger J, Klughammer J, Ergüner B, Bauer M, Brada M, Chong K, Brandner-Kokalj T, Freyschlag CF, Grams A, Haybaeck J, Hoenigschnabl S, Hoffermann M, Iglseder S, Kiesel B, Kitzwoegerer M, Kleindienst W, Marhold F, Moser P, Oberndorfer S, Pinggera D, Scheichel F, Sherif C, Stockhammer G, Stultschnig M, Thomé C, Trenkler J, Urbanic-Purkart T, Weis S, Widhalm G, Wuertz F, Preusser M, Baumann B, Simonitsch-Klupp I, Nam DH, Bock C, Langs G, Woehrer A. Nenning KH, et al. Among authors: urbanic purkart t. Neurooncol Adv. 2023 Oct 18;5(1):vdad136. doi: 10.1093/noajnl/vdad136. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024240 Free PMC article.
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.
Darlix A, Mandonnet E, Freyschlag CF, Pinggera D, Forster MT, Voss M, Steinbach J, Loughrey C, Goodden J, Banna G, Di Blasi C, Foroglou N, Hottinger AF, Baron MH, Pallud J, Duffau H, Rutten GJ, Almairac F, Fontaine D, Taillandier L, Pessanha Viegas C, Albuquerque L, von Campe G, Urbanic-Purkart T, Blonski M. Darlix A, et al. Among authors: urbanic purkart t. Neurooncol Pract. 2019 Jul;6(4):264-273. doi: 10.1093/nop/npy051. Epub 2018 Dec 13. Neurooncol Pract. 2019. PMID: 31386080 Free PMC article.
Poor short-term outcome in patients with ischaemic stroke and active cancer.
Kneihsl M, Enzinger C, Wünsch G, Khalil M, Culea V, Urbanic-Purkart T, Payer F, Niederkorn K, Fazekas F, Gattringer T. Kneihsl M, et al. Among authors: urbanic purkart t. J Neurol. 2016 Jan;263(1):150-6. doi: 10.1007/s00415-015-7954-6. Epub 2015 Nov 3. J Neurol. 2016. PMID: 26530513
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P; VITDALIZE Collaboration Group. Amrein K, et al. BMJ Open. 2019 Nov 12;9(11):e031083. doi: 10.1136/bmjopen-2019-031083. BMJ Open. 2019. PMID: 31722941 Free PMC article.
12 results